| Schedule of Revenue Disaggregated by Product and Geographical Area |
The following table summarizes the Company's net product sales disaggregated by product and geographic area: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | (in thousands) | | 2025 | | 2024 | | 2025 | | 2024 | Galafold® U.S. | | $ | 53,600 | | | $ | 42,770 | | | $ | 93,766 | | | $ | 76,885 | | Galafold® Ex-U.S. | | 75,272 | | | 68,047 | | | 139,350 | | | 133,291 | | Total Galafold® sales | | $ | 128,872 | | | $ | 110,817 | | | $ | 233,116 | | | $ | 210,176 | | Pombiliti® + Opfolda® U.S. | | $ | 10,730 | | | 7,368 | | | 20,557 | | | 10,628 | | Pombiliti® + Opfolda® Ex-U.S. | | 15,086 | | | 8,484 | | | 26,264 | | | 16,268 | | Total Pombiliti® + Opfolda® sales | | $ | 25,816 | | | $ | 15,852 | | | $ | 46,821 | | | $ | 26,896 | | | Total net product sales | | $ | 154,688 | | | $ | 126,669 | | | $ | 279,937 | | | $ | 237,072 | |
|